CA2696288A1 - 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 - Google Patents
6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 Download PDFInfo
- Publication number
- CA2696288A1 CA2696288A1 CA2696288A CA2696288A CA2696288A1 CA 2696288 A1 CA2696288 A1 CA 2696288A1 CA 2696288 A CA2696288 A CA 2696288A CA 2696288 A CA2696288 A CA 2696288A CA 2696288 A1 CA2696288 A1 CA 2696288A1
- Authority
- CA
- Canada
- Prior art keywords
- azabicyclo
- trimethyl
- sulfonyl
- octane
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- AUBIJFWBGXBUSH-UHFFFAOYSA-N CC(c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O)O Chemical compound CC(c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O)O AUBIJFWBGXBUSH-UHFFFAOYSA-N 0.000 description 5
- 0 CC(C1)(C2)CC(C)(C)CC1*2[N+](c(ccc(N)c1)c1N)([O-])O Chemical compound CC(C1)(C2)CC(C)(C)CC1*2[N+](c(ccc(N)c1)c1N)([O-])O 0.000 description 4
- QVWMGGOAYKSOIX-UHFFFAOYSA-N CCC(C)(C)c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O Chemical compound CCC(C)(C)c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O QVWMGGOAYKSOIX-UHFFFAOYSA-N 0.000 description 2
- WQEQUIUCFPPDCE-UHFFFAOYSA-N CC(C)(CC(C)(C1)C2)C1N2S(c1cc([N+](C)([O-])[O-])c(C)cc1)(=O)=O Chemical compound CC(C)(CC(C)(C1)C2)C1N2S(c1cc([N+](C)([O-])[O-])c(C)cc1)(=O)=O WQEQUIUCFPPDCE-UHFFFAOYSA-N 0.000 description 1
- QOQKAAGWUMCYGW-UHFFFAOYSA-N CC(C)(CC(C)(C1)C2)C1N2S(c1ccc(CCC(OC)=O)cc1)(=O)=O Chemical compound CC(C)(CC(C)(C1)C2)C1N2S(c1ccc(CCC(OC)=O)cc1)(=O)=O QOQKAAGWUMCYGW-UHFFFAOYSA-N 0.000 description 1
- GSQQOCQRYUDKQA-UHFFFAOYSA-N CC(C)(c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O)O Chemical compound CC(C)(c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O)O GSQQOCQRYUDKQA-UHFFFAOYSA-N 0.000 description 1
- SFQQVKGSFBZABW-UHFFFAOYSA-N CC(C)(c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O)OC Chemical compound CC(C)(c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O)OC SFQQVKGSFBZABW-UHFFFAOYSA-N 0.000 description 1
- AGMHVBMOFHSQOH-UHFFFAOYSA-N CC(C1)(C2)CC(C)(C)CC1N2C(c(cc1)ccc1S(C)(=O)=O)=O Chemical compound CC(C1)(C2)CC(C)(C)CC1N2C(c(cc1)ccc1S(C)(=O)=O)=O AGMHVBMOFHSQOH-UHFFFAOYSA-N 0.000 description 1
- MCGXVIKPUNPYLR-UHFFFAOYSA-N CC(C1)(C2)CC(C)(C)CC1N2S(c(c(C)n[n]1C)c1Cl)(=O)=O Chemical compound CC(C1)(C2)CC(C)(C)CC1N2S(c(c(C)n[n]1C)c1Cl)(=O)=O MCGXVIKPUNPYLR-UHFFFAOYSA-N 0.000 description 1
- RSCNWESDVSUEDX-UHFFFAOYSA-N CC(C1)(C2)CC(C)(C)CC1N2S(c(cn1)ccc1Oc1ccccc1)(=O)=O Chemical compound CC(C1)(C2)CC(C)(C)CC1N2S(c(cn1)ccc1Oc1ccccc1)(=O)=O RSCNWESDVSUEDX-UHFFFAOYSA-N 0.000 description 1
- ZRDDXSDYDVYFKW-UHFFFAOYSA-N CC(C1)(C2)CC(C)(C)CC1N2S(c1ccc(N2CCOCC2)nc1)(=O)=O Chemical compound CC(C1)(C2)CC(C)(C)CC1N2S(c1ccc(N2CCOCC2)nc1)(=O)=O ZRDDXSDYDVYFKW-UHFFFAOYSA-N 0.000 description 1
- BGZBCCVCWZOQRJ-UHFFFAOYSA-N CCC(C)(c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O)O Chemical compound CCC(C)(c(cc1)ccc1S(N1C(C2)CC(C)(C)CC2(C)C1)(=O)=O)O BGZBCCVCWZOQRJ-UHFFFAOYSA-N 0.000 description 1
- KHKZWFXSRVDIIG-UHFFFAOYSA-N CCCC(CC(C)(CCC)CC1)N1S(c1ccc(C(C)(C)OC)cc1)(=O)=O Chemical compound CCCC(CC(C)(CCC)CC1)N1S(c1ccc(C(C)(C)OC)cc1)(=O)=O KHKZWFXSRVDIIG-UHFFFAOYSA-N 0.000 description 1
- QGQWJYBUAFUIRY-ULKQQTICSA-N C[C@@H]1C(C)(C2)CC(C)(C)CC1N2S(c(cc1)ccc1-c(cc1)ccc1Cl)(=O)=O Chemical compound C[C@@H]1C(C)(C2)CC(C)(C)CC1N2S(c(cc1)ccc1-c(cc1)ccc1Cl)(=O)=O QGQWJYBUAFUIRY-ULKQQTICSA-N 0.000 description 1
- ULKGBHSXTFKFDQ-QBHLMBNYSA-N C[C@@H]1C(C)(C2)CC(C)(C)CC1N2S(c(cc1)ccc1-c(cc1)ccc1OC)(=O)=O Chemical compound C[C@@H]1C(C)(C2)CC(C)(C)CC1N2S(c(cc1)ccc1-c(cc1)ccc1OC)(=O)=O ULKGBHSXTFKFDQ-QBHLMBNYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95598507P | 2007-08-15 | 2007-08-15 | |
| US60/955,985 | 2007-08-15 | ||
| PCT/US2008/009609 WO2009023181A1 (en) | 2007-08-15 | 2008-08-12 | 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11β-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2696288A1 true CA2696288A1 (en) | 2009-02-19 |
Family
ID=39944385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2696288A Abandoned CA2696288A1 (en) | 2007-08-15 | 2008-08-12 | 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8466149B2 (enExample) |
| EP (1) | EP2188293B1 (enExample) |
| JP (1) | JP2010536750A (enExample) |
| CN (1) | CN101821271A (enExample) |
| CA (1) | CA2696288A1 (enExample) |
| MX (1) | MX2010001825A (enExample) |
| WO (1) | WO2009023181A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| JPWO2019026575A1 (ja) * | 2017-08-04 | 2020-06-18 | 国立大学法人東海国立大学機構 | 花成時期調節剤、農薬組成物及び植物の花成時期の調節方法 |
| WO2021242753A1 (en) * | 2020-05-26 | 2021-12-02 | The Regents Of The University Of Michigan | Mitochondrial targeting compounds for the treatment of associated diseases |
| CN111743898A (zh) * | 2020-06-11 | 2020-10-09 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 11β-HSD1抑制剂在应激环境下保护神经干细胞的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL154306A0 (en) | 2003-02-05 | 2003-09-17 | Rimonyx Pharmaceuticals Ltd | Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof |
| EP1948657A1 (en) | 2005-11-15 | 2008-07-30 | Vertex Pharmaceuticals Incorporated | Azaindazoles useful as inhibitors of kinases |
| JP5782586B2 (ja) * | 2007-05-10 | 2015-09-24 | ドッグウッド ファーマシューティカルズ，インコーポレイテッド | フルオレン、アントラセン、キサンテン、ジベンゾスベロン、及びアクリジンの誘導体、並びに、それらの使用 |
-
2008
- 2008-08-12 CN CN200880112336A patent/CN101821271A/zh active Pending
- 2008-08-12 CA CA2696288A patent/CA2696288A1/en not_active Abandoned
- 2008-08-12 JP JP2010521002A patent/JP2010536750A/ja not_active Withdrawn
- 2008-08-12 US US12/672,817 patent/US8466149B2/en active Active
- 2008-08-12 EP EP08795217.2A patent/EP2188293B1/en active Active
- 2008-08-12 MX MX2010001825A patent/MX2010001825A/es not_active Application Discontinuation
- 2008-08-12 WO PCT/US2008/009609 patent/WO2009023181A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20110237559A1 (en) | 2011-09-29 |
| CN101821271A (zh) | 2010-09-01 |
| EP2188293A1 (en) | 2010-05-26 |
| EP2188293B1 (en) | 2019-05-01 |
| MX2010001825A (es) | 2010-03-10 |
| US8466149B2 (en) | 2013-06-18 |
| JP2010536750A (ja) | 2010-12-02 |
| WO2009023181A1 (en) | 2009-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8604195B2 (en) | Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1 | |
| US8580807B2 (en) | Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders | |
| EP2188293B1 (en) | 6-substituted sulfonyl azabicycloý3.2.1¨octanes useful to inhibit 11 -hydroxysteroid dehydrogenase type-1 | |
| US8815876B2 (en) | Bicyclic heterocycle derivatives and methods of use thereof | |
| US20120232073A1 (en) | Fused bicyclic pyrimidine derivatives and methods of use thereof | |
| US8410122B2 (en) | Bicyclic heterocycle derivatives and methods of use thereof | |
| US20110118286A1 (en) | Bicyclic heterocycle derivatives and their use as gpcr modulators | |
| US9409918B2 (en) | Bridged bicyclic piperidine derivatives and methods of use thereof | |
| EP2382204B1 (en) | Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes | |
| US20110129542A1 (en) | Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 | |
| US8912206B2 (en) | Pyrimidine ether derivatives and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |